Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Enrollment opens in phase II study of maralixibat for infants with biliary atresia

Feb. 25, 2021

Dosing begins in first-in-human study of LG-00303174 for NASH

Feb. 23, 2021

U-ACCOMPLISH induction study of upadacitinib meets primary and all ranked secondary endpoints

Feb. 23, 2021

Ascletis reports data on ASC-41 in overweight and obese subjects

Feb. 22, 2021

PTGER4 as new therapeutic target to promote intestinal macrophage healing in IBD

Feb. 22, 2021

Bettering bile: New organoid marks progress to liver repair beyond hepatocytes

Feb. 19, 2021

Hoth plans to expand development of HT-003 for inflammatory bowel diseases

Feb. 19, 2021

Positive topline data from investigator-sponsored phase II study of IMU-838 in PSC

Feb. 19, 2021

Incannex expands development of IHL-675A to include inflammatory bowel disease

Feb. 17, 2021

Phase II study of SHR-0302 in ulcerative colitis meets primary endpoint

Feb. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...